Mark Chao

Co-Founder at Forty Seven, Inc.

Mark Chao

Mark Chao

Co-Founder at Forty Seven, Inc.

Biography

Mark Chao founded Forty Seven, Inc. and Hepatx Corp. Currently, Dr. Chao is Vice President-Clinical Development at Forty Seven, Inc.

Overview
Career Highlights

Forty Seven, Inc.
Hepatx

RelSci Relationships

237

Contact Data
Trying to get in touch with Mark Chao? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Mark Chao likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Forty Seven, Inc.

Relationship likelihood: Strong

Non-Resident Fellow at The Salk Institute for Biological Studies

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Forty Seven, Inc.

Relationship likelihood: Strong

Venture Partner, Enterprise at Lightspeed Management Co. LLC

Relationship likelihood: Strong

Managing Director at Sutter Hill Ventures LLC

Relationship likelihood: Strong

Chief Business Officer at Forty Seven, Inc.

Relationship likelihood: Strong

Chief Medical Officer at Forty Seven, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Principal Accounting Officer at Forty Seven, Inc.

Relationship likelihood: Strong

Chief Patent Counsel at Forty Seven, Inc.

Relationship likelihood: Strong

Founder & Vice President Research & Early Development at Forty Seven, Inc.

Relationship likelihood: Strong

Paths to Mark Chao
Potential Connections via
Relationship Science
You
Mark Chao
Co-Founder at Forty Seven, Inc.
Education
Ph.D Cancer Biology
Class of 2011

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

BA Biology
Class of 2004

Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH.

Career History
Co-Founder
2014 - Current

Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA.

Co-Founder
Current

HepaTx is developing regenerative medicine solutions to address the need for better therapies for life-threatening liver diseases. The technology invented at Stanford University enables efficient hepatocyte production for therapeutic purposes. Its therapeutics can replace lost liver function to treat those with end-stage of liver disease, potentially saving the cost and morbidity of whole organ transplant. Hepatx was established in 2015 and is based in Palo Alto, California.

Hematology Fellow
Current

Stanford Hospital is part of the Stanford University Medical Center along with the Lucile Packard Children's Hospital and the Stanford School of Medicine. It is world-renowned for its work in cardiovascular medicine and surgery, organ transplantation, neurology, neurosurgery, and cancer diagnosis and treatment.

Investments
Details Hidden

Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA.

Other Affiliations

Mark Chao is affiliated with Forty Seven, Inc., Hepatx, Stanford Health Care

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Mark Chao. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Mark Chao's profile does not indicate a business or promotional relationship of any kind between RelSci and Mark Chao.